Quest Diagnostics reports Q3 adjusted EPS $2.30, consensus $2.26

Reports Q3 revenue $2.49B, consensus $2.42B. “We delivered a strong third quarter, with total revenue growth of 8.5%, including 4.2% organic growth,” said Jim Davis, chairman, CEO and president. “Our performance was driven by new customer wins and expanded business with physicians and hospitals as well as recent acquisitions, including LifeLabs. We are now on track to complete eight acquisitions by year’s end that meet our criteria for profitability, growth and returns.”